Glucocorticoid-induced MIF expression by human CEM T cells. 2009

Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
Yale University School of Medicine, New Haven, CT 06520, USA.

Macrophage migration inhibitory factor (MIF) is an upstream activator of the immune response that counter-regulates the immunosuppressive effects of glucocorticoids. While MIF is released by cells in response to diverse microbial and invasive stimuli, evidence that glucocorticoids in low concentrations also induce MIF secretion suggests an additional regulatory relationship between these mediators. We investigated the expression of MIF from the human CEM T cell line, which exists in two well-characterized, glucocorticoid-sensitive (CEM-C7) and glucocorticoid-resistant (CEM-C1) variant clones. Dexamethasone in low concentrations induced MIF secretion from CEM-C7 but not CEM-C1 T cells by a bell-shaped dose response that was similar to that reported previously for the release of MIF by monocytes/macrophages. Glucocorticoid stimulation of CEM-C7 T cells was accompanied by an MIF transcriptional response, which by promoter analysis was found to involve the GRE and ATF/CRE transcription factor binding sites. These data support a glucocorticoid-mediated MIF secretion response by T cells that may contribute to the regulation of the adaptive immune response.

UI MeSH Term Description Entries
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
November 1996, Cancer research,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
January 1988, Leukemia research,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
February 2010, Biochemical pharmacology,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
March 1999, Cancer research,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
March 2003, The Journal of infectious diseases,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
June 2003, Genomics,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
June 2006, Biochemical and biophysical research communications,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
August 2001, Oncogene,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
January 2001, Anticancer research,
Lin Leng, and Wenkui Wang, and Thierry Roger, and Melanie Merk, and Martina Wuttke, and Thierry Calandra, and Richard Bucala
November 2004, International journal of cancer,
Copied contents to your clipboard!